Clinical Trials in Atlanta

Showing 19661-19680 of 19,805 trials

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

NCT00100724

The purpose of this study is to assess the safety and immunogenicity of rPA102 vaccine given intramuscularly at 0 and 4 weeks over 2 dose ranges and 4 adjuvant levels.

Anthrax

VaxGen480 participantsStarted Apr 2004

Torrance, California, United States • Atlanta, Georgia, United States • Lexington, Kentucky, United States +9 more locations

COMPLETEDPhase 2< 1 mile

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

NCT00087542

The primary objective is to demonstrate that the investigational new drug, ACP-103, is well tolerated by, and will not worsen parkinsonism in, patients with Parkinson's disease and psychosis. The secondary objectives are to determine whether ACP-103 will ameliorate psychosis in patients with Parkinson's disease and whether ACP-103 is safe in Parkinson's disease patients taking multiple anti-parkinsonian medications.

HallucinationsPsychosesParkinson's Disease

ACADIA Pharmaceuticals Inc.60 participantsStarted Mar 2004

Fountain Valley, California, United States • Sunnyvale, California, United States • Danbury, Connecticut, United States +10 more locations

Trial of rPA-102 Vaccine in Healthy Adult Volunteers

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Find Trials by Condition in Atlanta

A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Xcellerated T CellsTM in Patients With Multiple Myeloma

Effectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial Seizures

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase I Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile Of Lenalidomide (Revlimid®, CC-5013) With Pemetrexed In Subjects With Advanced Non-Small Cell Lung Cancer

Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain

Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies

Study to Demonstrate That Muscle Pattern Recognition (MPR) is an Effective Evaluation Tool for Musculoskeletal Neck or Back Pain

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Study of NS-9 in Patients With Liver Metastases